Dow Down 0.18% Nasdaq Up 0.39%

More On SKP.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

SkyePharma plc (SKP.L)

-LSE
306.25 Down 10.50(3.31%) 11:35AM EDT
Prev Close:316.75
Open:317.00
Bid:165.00
Ask:360.00
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:305.00 - 317.59
52wk Range:78.00 - 317.59
Volume:202,050
Avg Vol (3m):455,375
Market Cap:201.20M
P/E (ttm):18,014.71
EPS (ttm):0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Headlines

  • No Headlines available for SKP.L at this time.

Key Statistics

Forward P/E (1 yr):0.11
P/S (ttm):316.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :15.20
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC, an oral and inhalation drug delivery company, develops, manufactures, and sells oral and inhalation pharmaceutical products. Its marketed products include flutiform and ZYFLO CR for treating asthma; Relvar Ellipta/Breo Ellipta for ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback